Milestone Pharmaceuticals Inc. (MIST) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Milestone Pharmaceuticals Inc. (MIST) closed at USD 0.80 on 2026-10-15, a change of -56.8 % over the past year, with a market capitalization of USD 88.06M.

Milestone Pharmaceuticals Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Milestone Pharmaceuticals Inc. key figures

Previous close

USD 0.80 (2026-10-15)

1-year change

-56.8 %

Market cap

USD 88.06M

Enterprise value

USD 70.89M

P/E ratio (trailing)

-1.04

P/E ratio (forward)

-0.92

EPS (trailing)

-0.68

EPS (forward)

-0.77

PEG ratio

n/a

Price to book

5.48

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

13.18

Employees

38

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Milestone Pharmaceuticals Inc. and compare it with other stocks.